We found that female aduit mice parenterally inoculated with noninfectious rotavirus (simian strain RRV) developed virus-specific neutralizing antibodies in the serum; newborn mice from these dams were protected against RRV-induced gastroenteritis. In addition, mice parenterally inoculated with noninfectious RRV developed virus-specific cytotoxic T-lymphocyte precursors in the spleen. Replication of rotavirus in intestinal epithelial cells was apparently not required to induce rotavirus-neutralizing antibodies or rotavirus-specific cytotoxic T lymphocytes. Parenteral immunization of infants and young children with noninfectious rotaviruses may induce an immune response which protects against rotavirus challenge.
Rotaviruses are the most important cause of infant and childhood gastroenteritis both in developed countries and in developing countries (2, 13) . Because of the devastating impact of this pathogen, there is a great deal of interest in disease prevention by vaccine. Currently, two rotavirus candidate vaccine strains (WC3 and RRV) are being tested in large-scale trials of protective efficacy in infants and young children (3, 12) . Strains WC3 and RRV are live rotaviruses originally isolated from the feces of a calf and a rhesus monkey, respectively (4, 26) .
Rotaviruses cause disease by replicating in mature villus epithelial cells of the small intestine (25) . Although nonhuman rotaviruses are probably less adapted to growth in the human intestine than are human strains, children orally inoculated with RRV shed infectious virus as long as 7 days after inoculation (14) . In addition, children inoculated with RRV develop fever more frequently than placebo-inoculated controls (14) . Therefore, immunization with rotavirus vaccines which do not replicate in the intestine (such as inactivated whole rotaviruses, purified rotavirus proteins, or rotavirus genes cloned into attenuated viral or bacterial vectors) may be useful.
In this study, we found that adult mice parenterally inoculated with noninfectious RRV developed RRV-specific neutralizing antibodies in the serum and RRV-specific cytotoxic T-lymphocyte (CTL) precursors in the spleen. In addition, newborn mice from dams parenterally immunized with noninfectious RRV were protected against RRV-induced gastroenteritis. Replication of rotavirus in intestinal epithelial cells was (20) . Tissue culture stocks of RRV mixed with various concentrations of ,B-propiolactone (BPL) were maintained at 4°C for 72 h and then at 37°C for 3 h. Tissue culture stocks of RRV in a fluid layer approximately 1.0 mm thick (2.5 ml/60-mm-diameter petri dish) were exposed for 10 min at room temperature to UV light from a General Electric germicidal lamp (G30T8; 30W, 90 cm) placed directly above the petri dishes at a distance of 19.0 cm. BPL-and UV-treated RRV preparations were tested for viral infectivity and hemagglutination activity as previously described (10, 20) .
Protection against rotavirus-induced diarrhea. (i) Immunization and handling of dams. Female C57BL6 mice (8 to 10 weeks old) were parenterally inoculated with either 107 PFU of RRV inactivated with 0.10% BPL plus UV irradiation or an equivalent volume of supernatant fluids from mockinfected MA-104 cells. On the day of inoculation, female mice were mated with C57BL6 males at a female-to-male ratio of 1:1.
(ii) Infection of infant mice. Seven-day-old mice were orally inoculated with 106 PFU of RRV (approximately 10 times the dose at which 50% of inoculated animals develop diarrhea) (22 Suckling mice are protected against RRV-induced gastroenteritis after inoculation of dams with noninfectious RRV. To determine whether noninfectious RRV induced antibodies which passively protected suckling mice against rotavirusinduced diarrhea, adult female mice were parenterally inoculated with noninfectious RRV or supernatant fluid from mock-infected MA-104 cells and their newborns were challenged with RRV. We found that noninfectious RRV induced rotavirus-neutralizing antibodies in dams and that newborns orally challenged with RRV were protected against disease (Table 3) ; newborns from dams parenterally inoculated with supernatant fluids from mock-infected cells were not protected against challenge. DISCUSSION We detected rotavirus-specific neutralizing antibodies in sera of dams parenterally inoculated with noninfectious RRV. Newborns to which neutralizing antibodies from these dams were passively transferred were protected against RRV challenge. Therefore, replication of rotavirus in intestinal epithelial cells was not required to induce an immune response which passively protected suckling mice against rotavirus challenge. Protection against RRV challenge was most likely mediated by passively transferred rotavirusspecific immunoglobulin G present at the intestinal surface. It is unlikely that passively transferred rotavirus-specific helper T cells or CTLs were responsible for protection against challenge. These conclusions are based on the following findings. (i) We previously found that oral administration of milk from dams parenterally immunized with simian rotavirus (strain SA11) protected suckling mice against SA11 challenge; protective activity was detected in the rotavirus-specific immunoglobulin G fraction (17) . (ii) In cross-fostering studies, we found that passively acquired rotavirus-specific intestinal but not circulating antibodies protected against challenge (17 teral inoculation of adult mice with RRV protected newborns against challenge with murine rotavirus strain JMV (data not shown). Presumably, rotavirus-specific lymphocytes acquired orally do not migrate efficiently through the mucus layer to the intestinal cell surface.
The rotavirus outer capsid consists of two proteins, vp4 and vp7 (5) . Rotavirus attachment to target cells is mediated by vp7 (6, 24) . Virus entry into the cytoplasm, on the other hand, is a function of vp4 (6, 11) . Both vp4 and vp7 evoke antibodies which neutralize viral infectivity in vitro (8, 16) and protect against rotavirus challenge in vivo (7, 18) . We found that RRV infectivity was completely ablated by treatment with 0.15% BPL or 0.10% BPL plus UV irradiation. However, treatment of RRV with BPL also altered the structural integrity of outer-capsid proteins as indirectly reflected in decreased viral hemagglutinating activity. Despite this alteration of rotavirus outer-capsid proteins, parenteral inoculation of mice with BPL-treated RRV evoked virus-specific neutralizing antibodies. These findings are similar to those previously described for noninfectious preparations of poliovirus (23) and rabies virus (29 50 ,ug of purified, noninfectious bovine rotavirus per inoculation developed rotavirus-specific antibodies in milk detected by enzyme-linked immunosorbent assay; studies of protection against rotavirus challenge were not performed (9) .
We previously detected rotavirus-specific CTL precursors in spleens of adult mice orally inoculated with infectious RRV (21) . However, parenteral inoculation of adult mice with noninfectious RRV also induced virus-specific CTL precursors in the spleen (Table 2) . Therefore, viral replication was not necessary to induce rotavirus-specific CTL precursors. Virus-specific CTL precursors have previously been detected in splenic lymphocytes after parenteral inoculation of mice with noninfectious preparations of respiratory syncytial virus (1), influenza virus (28), and Sendai virus (27) . The importance of rotavirus-specific CTLs in protection against gastroenteritis remains unknown.
Parenteral inoculation of adult mice with noninfectious RRV induced RRV-specific neutralizing antibodies in serum and RRV-specific CTL precursors in the spleen. Replication of rotavirus in intestinal epithelial cells was not required to induce virus-specific immunity. These findings may be relevant to the development of a successful rotavirus vaccine.
